Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma

Human Pathology

Volumn 40, Issue 5, 2009, Pages 726-734

  Ahmad, Imran ^a   Iyer, Anita ^b   Marginean, Celia E ^c   Yeh, Matthew M ^d   Ferrell, Linda ^e   Qin, Lihui ^f   Bifulco, Carlo B ^a   Jain, Dhanpat ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokeratin, NCAM; Focal nodular hyperplasia; Hepatic adenoma; Immunohistochemistry

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 7; NERVE CELL ADHESION MOLECULE;

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CELL; LIVER HYPERPLASIA; NEEDLE BIOPSY; SCHOOL CHILD; TELANGIECTATIC LIVER FOCAL NODULAR HYPERPLASIA;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BIOPSY, NEEDLE; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; KERATIN-7; LIVER NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 64049116606     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.10.018     Document Type: Article

References (27)

1. Goodman Z.D., and Terracciano L.M. Tumor and tumor-like lesions of the liver. In: Burt A.D., Portman B.C., and Ferrell L.D. (Eds). MacSween's pathology of liver. 5th ed (2007), Churchill Livingstone, Philadelphia 762-767.
2. Choi B.Y., and Nguyen M.H. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 39 (2005) 401-412
3. Iyer A., Robert M.E., Bifulco C.B., Salem R.R., and Jain D. Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance. Hum Pathol 39 (2008) 1370-1377
4. Libbrecht L., De Vos R., Cassiman D., et al. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 25 (2001) 1388-1396
5. Makhlouf H.R., Abdul-Al H.M., and Goodman Z.D. Diagnosis of focal nodular hyperplasia of the liver by needle biopsy. Hum Pathol 36 (2005) 1210-1216
6. Roskams T., De Vos R., and Desmet V. 'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology 28 (1996) 291-299
7. Theuerkauf I., Zhou H., and Fischer H.P. Immunohistochemical patterns of human liver sinusoids under different conditions of pathologic perfusion. Virchows Arch 438 (2001) 498-504
8. Pusztaszeri M.P., Seelentag W., and Bosman F.T. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54 (2006) 385-395
9. Hytiroglou P., and Theise N.D. Differential diagnosis of hepatocellular nodular lesions. Semin Diagn Pathol 15 (1998) 285-299
10. Charny C.K., Jarnagin W.R., Schwartz L.H., et al. Management of 155 patients with benign liver tumours. Br J Surg 88 (2001) 808-813
11. Nguyen B.N., Flejou J.F., Terris B., Belghiti J., and Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23 (1999) 1441-1454
12. Shimizu S., Takayama T., Kosuge T., et al. Benign tumors of the liver resected because of a diagnosis of malignancy. Surg Gynecol Obstet 174 (1992) 403-407
13. Zhou H., Rogler L.E., Teperman L., Morgan G., and Rogler C.E. Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology 45 (2007) 716-724
14. Kong C.S., Appenzeller M., and Ferrell L.D. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy. Acta Cytol 44 (2000) 218-222
15. Dhillon A.P., Colombari R., Savage K., and Scheuer P.J. An immunohistochemical study of the blood vessels within primary hepatocellular tumours. Liver 12 (1992) 311-318
16. Roskams T., Yang S.Q., Koteish A., et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 163 (2003) 1301-1311
17. Clouston A.D., Powell E.E., Walsh M.J., et al. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 41 (2005) 809-818
18. Benz E.J., and Baggenstoss A.H. Focal cirrhosis of the liver: its relation to the so-called hamartoma (adenoma, benign hepatoma). Cancer 6 (1953) 743-755
19. Bioulac-Sage P., Rebouissou S., Thomas C., et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46 (2007) 740-748
20. Paradis V., Benzekri A., Dargere D., et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126 (2004) 1323-1329
21. Handra-Luca A., Paradis V., Vilgrain V., et al. Multiple mixed adenoma-focal nodular hyperplasia of the liver associated with spontaneous intrahepatic porto-systemic shunt: a new type of vascular malformation associated with the multiple focal nodular hyperplasia syndrome?. Histopathology 48 (2006) 309-311
22. Lepreux S., Laurent C., Balabaud C., and Bioulac-Sage P. FNH-like nodules: possible precursor lesions in patients with focal nodular hyperplasia (FNH). Comp Hepatol 2 (2003) 7
23. Torbenson M., Lee J.H., Choti M., et al. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol 15 (2002) 189-196
24. Kakar S., Gown A.M., Goodman Z.D., and Ferrell L.D. Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med 131 (2007) 1648-1654
25. Durnez A., Verslype C., Nevens F., et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49 (2006) 138-151
26. Kim Y.D., Park C.H., Kim H.S., et al. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma. J Gastroenterol Hepatol 23 (2008) 110-118
27. Austinat M., Dunsch R., Wittekind C., et al. Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer 7 (2008) 21